OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM)

Historical Holders from Q2 2021 to Q4 2024

Symbol
RPHM on Nasdaq
CUSIP
75974E103
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
12.7M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.53K
Holdings value
$2.59K
Grand Portfolio weight change
0%
Number of holders
1
Number of sells
-45
Average Value change %
0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RiverVest Venture Fund III, L.P. 1.55% $334K 196K John P. McKearn, Ph.D. Jan 16, 2025

Institutional Holders of OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 1.53K $2.59K -$44.7M $1.70 1
2024 Q3 28.8M $49M +$2.87M $1.70 48
2024 Q2 27.3M $41.3M +$1.42M $1.51 62
2024 Q1 390K $648K -$1.85M $1.66 11
2023 Q4 25.2M $40.4M -$64.4M $1.60 66
2023 Q3 27.4M $208M +$9.83M $7.62 58
2023 Q2 26.2M $169M +$60M $6.56 51
2023 Q1 17.1M $102M +$16.2M $5.98 34
2022 Q4 16.5M $38.4M -$201K $2.33 32
2022 Q3 16.4M $55.1M +$278K $3.35 31
2022 Q2 16.4M $43.3M -$2.67M $2.65 29
2022 Q1 17.3M $50.8M -$721K $2.94 38
2021 Q4 17.4M $149M -$7.19M $8.55 38
2021 Q3 18.4M $119M +$103K $7.45 38
2021 Q2 15.9M $148M +$148M $9.33 36